The United States is facing a crisis when it comes to health care costs. Prices for lifesaving, necessary care and drugs are simply too high for consumers.
Ever-rising health care costs are causing many across the political spectrum to rethink their priorities and positions on key health care policy issues.
Operating largely beneath the public and regulatory radar, private equity firms have gravitated toward health care over the past decade in pursuit of outsized profits.
An eleventh-hour bid by private equity companies, hospitals and other provider interests threatens to torpedo Congress’ objectives of protecting patients from exorbitant, surprise medical bills and constraining soaring health care costs.
This year’s landmark federal rule requiring the nation’s 6,000 hospitals to begin making pricing data available publicly was supposed to help consumers and purchasers shop more intelligently for health care services. But whether that’s actually occurring seems questionable.
Health care leaders are looking to work together differently to ensure COVID-19 vaccines are delivered in an effective, equitable manner.
Depression screening is an essential tool for primary care providers to better understand and meet their patients’ needs.
Employers have a critical role to play in helping end the COVID-19 pandemic by encouraging vaccine acceptance and uptake among their employees.
Telehealth holds great promise for improving primary care through increasing access, improving patient experience and enabling team-based care models.
Faced with Republican resistance on the size and scope of their proposed COVID-19 response legislation, the $1.9 trillion American Rescue Act, Capitol Hill Democrats are attempting to do something no Congress has succeeded in doing since 2006 – pass two budget reconciliation bills in a single year.